Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 12 Best NASDAQ Penny Stocks to Buy According to Hedge Funds. On ...

Recursion Pharmaceuticals (RXRX) closed at $4.77 in the latest trading session, marking a -1.24% move from the prior day. This change lagged the S&P 500's 0.47% gain on the day. Meanwhile, the Dow ...

Nvidia owned six AI stocks at the end of Q2. Most of them remain unprofitable. One stock in Nvidia's portfolio stands out ...

Who is Deedy Das? Kolkata-born technologist and ‘AI startup whisperer’ Deedy Das has been promoted to Partner at Menlo Ventures, driving its AI investment strategy.

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

Absci uses OCI’s AMD EPYC-powered bare metal instances to speed up molecular simulations and antibody design. Hypervisor ...

ComplyAdvantage revolutionises financial crime detection through artificial intelligence and machine learning technology ...

Pharma layoffs in 2025 have surged, with thousands facing job cuts as companies like BMS and Novartis streamline operations.

Saylor, long known as the co-founder and head of enterprise-software firm Strategy (previously MicroStrategy), made his first ...

Detailed price information for Revolution Medicines Inc (RVMD-Q) from The Globe and Mail including charting and trades.

Biodexa Pharmaceuticals PLC (BDRX) has initiated its first clinical site in the U.S. for a phase 3 trial of eRapa, an oral ...